Company profile for Tolerance Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tolerance Bio is a pioneering biopharmaceutical company dedicated to developing novel treatments for immune-mediated diseases. Focused on innovative therapies that promote immune tolerance, Tolerance Bio aims to improve the lives of patients with chronic and complex immune conditions. By advancing cutting-edge research and collaborating with the scientific community, Tolerance Bio is committed to creating effective, targeted t...
Tolerance Bio is a pioneering biopharmaceutical company dedicated to developing novel treatments for immune-mediated diseases. Focused on innovative therapies that promote immune tolerance, Tolerance Bio aims to improve the lives of patients with chronic and complex immune conditions. By advancing cutting-edge research and collaborating with the scientific community, Tolerance Bio is committed to creating effective, targeted therapies that address the root causes of immune dysfunction, offering hope and improved quality of life for those affected by autoimmune and inflammatory diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
808 Pinehurst Drive, Chapel Hill, NC 27517
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

CGT Asia

Not Confirmed

envelop Contact Supplier

CGT Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251027232982/en/Tolerance-Bios-Implanted-iPSC-derived-Thymic-Organoids-Enable-In-Vivo-Positive-Selection-of-Human-T-cells-and-Tumor-Burden-Reduction-in-Melanoma

BUSINESSWIRE
27 Oct 2025

https://www.pharmiweb.com/press-release/2025-09-08/tolerance-bio-and-zipcode-bio-announce-strategic-rd-collaboration-to-advance-targeted-thymus-therap

PHARMAWEB
08 Sep 2025

https://www.businesswire.com/news/home/20241219611154/en

BUSINESSWIRE
19 Dec 2024

https://www.businesswire.com/news/home/20241008134130/en

BUSINESSWIRE
15 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty